Pluristem granted approval to test placenta cell-based therapy in Israel

10/4/2013 | Pharmaceutical Business Review Online

Pluristem Therapeutics obtained clearance from the Israeli Ministry of Health to initiate a midstage trial of its PLacental eXpanded cells in patients with intermittent claudication. The trial in Israel will follow the same protocol used by Pluristem in its U.S. study, which involved around 150 patients.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA